Brightsurf Science News & Current Events

April 22, 2017
NASA satellite animation shows Tropical Storm Arlene 'eaten' by weather system
An animation created by NASA using imagery from NOAA's GOES-East satellite shows the North Atlantic Ocean's first tropical storm of the season being

Cleveland Clinic study finds obesity as top cause of preventable life-years lost
A team of researchers from Cleveland Clinic and New York University School of Medicine have found that obesity resulted in as much as 47 percent more life-years lost than tobacco, and tobacco caused similar life-years lost as high blood pressure.

New research sheds light on treating bloodstream infections with fewer side effects
Two presentations at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) from the INCREMENT study shed light on ways to treat bloodstream infections with fewer side effects and without the need for antimicrobials of 'last resort'.

Drug-resistant bacteria in patients' urine or stools raise risk of drug-resistant sepsis
People who have recently been found to have drug-resistant bacteria in their urine or stool samples have a greatly increased risk of developing a bloodstream infection that is also resistant to certain antibiotics, according to a study presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases.

Could genetics influence what we like to eat?
Gene variants could affect food preferences in healthy people, according to a new study.

4 exciting advances in food and nutrition research
New discoveries tied to how food affects our body and why we make certain food choices could help inform nutrition plans and policies that encourage healthy food choices.

Cold weather & fewer sun hours are associated with increased rates of alcoholic cirrhosis
New data presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, suggests that colder and less sunny regions of the world have higher rates of alcoholic cirrhosis, a disease caused by excessive drinking which results in irreversible scarring of the liver.

Scientists and engineers push the envelope for better heart health
Featured research includes a 'neuroprosthetic' device that restores cardiac function in patients with spinal cord injuries, 3-D printed heart valves, new leads for the treatment of clogged arteries, advances in stem cell therapy and new ways to visualize immune system dynamics.

Four exciting diabetes and obesity research discoveries
With more than one-third of adults in the US considered obese, researchers are searching for new ways to treat obesity and associated health problems such as type 2 diabetes.

Cancer research advances: 5 leads for better diagnosis and treatment
Featured research includes a non-invasive new screening approach for breast cancer, leads for drug discovery and insights on a cancer-protective diet.

Long-term treatment of decompensated cirrhosis with human albumin improves survival
Results from the ANSWER study showed that long-term administration of human albumin improves the survival rate of patients with decompensated cirrhosis.

New therapy has potential to advance the treatment of pediatric cholestatic liver diseases
Results from a study of a novel ileal bile acid transport inhibitor, A4250, demonstrated that it reduced levels of blood bile acids, which are characteristic of many liver diseases and often associated with severe liver damage, in children with cholestatic liver diseases.

Predicting severe liver disease: Obesity, insulin, diabetes, cholesterol, alcohol
A study conducted in Finland demonstrates that in the general population, central obesity, insulin resistance, diabetes, lipid abnormalities and high alcohol consumption were the strongest predictors of severe liver disease.

SIRT is better tolerated than sorafenib, but doesn't increase overall survival in HCC
Results of the SARAH trial demonstrate that SIRT resulted in median OS of 8.0 months compared to 9.9 months with sorafenib (p=0.179), in patients with locally advanced and inoperable HCC.

Trial of fibrate therapy in primary biliary cholangitis shows treatment is well tolerated
The results of the BEZURSO study, found that bezafibrate in combination with UDCA normalized prognostic markers of liver disease in patients with PBC with an inadequate response to UDCA.

Testing urine for particular proteins could be key to preventing kidney transplant failure
Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to research presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to